Coca-Cola Europacific Partners

Public consensus   -   Last updated 20/08/26

Contributors

  • 17 FY26 based on
  • 17 H2 FY26 based on
  • 17 Q3 FY26 based on
  • 17 FY27 based on
  • 16 FY28 based on
Reporting currency: EUR
Reporting unit: Millions
FY26
CONSENSUS
20/08/26
H2 FY26
CONSENSUS
20/08/26
Q3 FY26
CONSENSUS
20/08/26
FY27
CONSENSUS
20/08/26
FY28
CONSENSUS
20/08/26
Comparable (€m)
Revenue: Europe
15,939
8,029
4,357
16,455
16,970
Operating profit: Europe
2,292
1,159
n/a
2,430
2,570
Revenue: APS
5,631
2,818
1,304
5,927
6,257
Operating profit: APS
713
365
n/a
777
850
Revenue: Total CCEP
21,571
10,848
5,660
22,381
23,228
Gross profit: TOTAL CCEP
7,677
3,884
n/a
7,945
8,268
Operating profit: TOTAL CCEP
3,005
1,525
n/a
3,208
3,421
Net finance costs: TOTAL CCEP
257
139
n/a
265
282
Taxes: TOTAL CCEP
711
358
n/a
760
811
Profit after taxes: TOTAL CCEP
2,026
1,023
n/a
2,165
2,305
Non-controlling interests: TOTAL CCEP
43
19
n/a
47
51
Diluted EPS (€): TOTAL CCEP
4.49
2.28
n/a
4.91
5.35
Growth Rates: Europe
Volume growth (%) – NOT adjusted for consumption days
1.7
(1.4)
1.5
0.7
0.9
Comparable FX-Neutral revenue per unit case growth (%)
1.8
2.2
2.0
2.4
2.2
Comparable FX-Neutral revenue growth (%)
3.4
0.6
3.4
3.1
3.1
Comparable total revenue growth (%)
3.5
1.3
3.9
3.2
3.1
Growth Rates: APS
Volume growth (%) – NOT adjusted for consumption days
3.7
0.6
4.5
3.1
3.2
Comparable FX-Neutral revenue per unit case growth (%)
-0.0
2.2
1.1
2.2
2.3
Comparable FX-Neutral revenue growth (%)
3.4
1.6
5.6
5.3
5.4
Comparable total revenue growth (%)
2.3
4.3
6.8
4.9
5.2
Growth Rates: TOTAL CCEP
Volume growth (%) – NOT adjusted for consumption days
2.4
(0.7)
2.4
1.5
1.7
Comparable FX-Neutral revenue per unit case growth (%)
1.1
2.1
1.7
2.1
2.1
Comparable FX-Neutral revenue growth (%)
3.5
1.2
4.1
3.7
3.8
Comparable total revenue growth (%)
3.2
2.0
4.5
3.8
3.8
Comparable FX-Neutral cost of sales per unit case growth (%)
1.3
1.9
n/a
2.2
1.8
Comparable FX-Neutral operating profit growth (%)
7.3
6.6
n/a
6.6
6.6
Comparable operating profit growth (%)
7.0
7.4
n/a
6.7
6.5
Comparable FX-neutral diluted EPS growth (%)
9.3
7.4
n/a
9.0
9.1
Select metrics: TOTAL CCEP
Gross profit margin (%)
35.6
35.8
n/a
35.5
35.6
Operating profit margin (%)
13.9
14.1
n/a
14.3
14.7
Tax rate (%)
26.0
26.0
n/a
25.9
25.9
Other Items: TOTAL CCEP
Dividend per share (€)
2.21
1.39
n/a
2.41
2.63
Depreciation & amortisation (€m)
922
511
n/a
953
980
Capital expenditure (€m)
1,016
580
n/a
1,049
1,078
Free cashflow (€m)
1,847
1,437
n/a
1,996
2,120
Net debt/(cash) (€m)
9,934
9,880
n/a
9,883
9,860
Dividend payment (€m)
978
615
n/a
1,042
1,110

Disclaimer

Coca-Cola Europacific Partners plc (the “Company”) is not authorised or regulated by the UK Financial Conduct Authority and may not provide investment advice. The consensus data should not be construed as an invitation, inducement or recommendation to buy or sell securities of the Company or to engage in any other form of investment activity. In addition, the consensus data is not intended to constitute a financial promotion within the meaning of section 21 of the Financial Services and Markets Act 2000.

The consensus data are based on submissions from registered investment analysts as to the Company’s expected future performance. It is therefore speculative and forward-looking and subject to a number of uncertainties that may impact the Company’s actual performance. Vuma Financial Ltd. collects and analyses the submissions which form the basis of the consensus data and any Company information provided is publicly disclosed and available on the Company’s website, from Euronext.com, londonstockexchange.com and/or filed with the US Securities and Exchange Commission . The figures presented represent the arithmetic average of the submissions that have been provided, with each submission being given equal weight. Moreover, the data has not been adjusted to exclude any submission. It is assumed that the submissions reflect the analysts’ genuine opinions, forecasts, estimates, projections and predictions and that the analysts will, if relevant, identify and disclose all conflicts of interest that are known or reasonably expected to be known to relate to them. No analyst has been paid a fee, commission or received a non-monetary benefit from the Company or any person connected to the Company for their submission.